[Studies on blood coagulation and fibrinolytic activities in the three cases of cerebral infarction treated with urokinase. 1st report--120,000 I.U. administrated-- (author's transl)].
作者信息
Fujita S, Itoga T, Shou T, Yamamoto H, Ishikawa H
出版信息
Rinsho Ketsueki. 1978 Jun;19(6):850-8.
PMID:713046
Abstract
摘要
相似文献
1
2
3
[Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].[各种肾脏疾病患者的纤溶疗法研究。尿激酶的临床效果（作者译）]
Nihon Jinzo Gakkai Shi. 1981 Sep;23(9):1271-80.
4
[Experimental studies on the mode and amount of urokinase administration in thrombolytic therapy (author's transl)].溶栓治疗中尿激酶给药方式及剂量的实验研究（作者译）
Rinsho Ketsueki. 1977 Sep 30;18(9):1097-101.
5
[Use of urokinase during surgery: a new approach to the treatment of vascular obliterative disease (author's transl)].
Ann Med Interne (Paris). 1979;130(4):215-8.
6
7
Modifications in coagulation parameters induced by treatment associating urokinase (2000 u CTA/kg/h) with heparin.尿激酶（2000 u CTA/kg/h）与肝素联合治疗引起的凝血参数改变。
Thromb Haemost. 1979 Oct 31;42(3):945-54.
8
Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.蚓激酶治疗脑梗死前后凝血及组织型纤溶酶原激活物的变化
Clin Hemorheol Microcirc. 2000;23(2-4):213-8.
9
10
[Successful fibrinolytic treatment with urokinase six weeks after leg and pelvic vein thrombosis (author's transl)].
Dtsch Med Wochenschr. 1974 Nov 29;99(48):2457-9. doi: 10.1055/s-0028-1108154.
Zotero 插件